Peripheral arteriopathy caused by Notch3 gain-of-function mutation involves ER and oxidative stress and blunting of NO/sGC/cGMP pathway

Tools

Neves, Karla B. and Morris, Hannah E. and Alves-Lopes, Rhéure and Muir, Keith W. and Moreton, Fiona and Delles, Christian and Montezano, Augusto C. and Touyz, Rhian M. (2021) Peripheral arteriopathy caused by Notch3 gain-of-function mutation involves ER and oxidative stress and blunting of NO/sGC/cGMP pathway. Clinical Science, 135 (6). pp. 753-773. ISSN 0143-5221 (https://doi.org/10.1042/CS20201412)

[thumbnail of Neves-etal-CS-2021-Peripheral-arteriopathy-caused-by-Notch3-gain-of-function-mutation]
Preview
 Text. Filename: Neves_etal_CS_2021_Peripheral_arteriopathy_caused_by_Notch3_gain_of_function_mutation.pdf
Accepted Author Manuscript
License: Strathprints license 1.0
Download (987kB)| Preview

Abstract

Notch3 mutations cause Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL), which predisposes to stroke and dementia. CADASIL is characterised by vascular dysfunction and granular osmiophilic material (GOM) accumulation in cerebral small vessels. Systemic vessels may also be impacted by Notch3 mutations. However vascular characteristics and pathophysiological processes remain elusive. We investigated mechanisms underlying the peripheral vasculopathy mediated by CADASIL-causing Notch3 gain-of-function mutation. We studied: (i) small arteries and vascular smooth muscle cells (VSMCs) from TgNotch3R169C mice (CADASIL model), (ii) VSMCs from peripheral arteries from CADASIL patients, and (iii) post-mortem brains from CADASIL individuals. TgNotch3R169C vessels exhibited GOM deposits, increased vasoreactivity and impaired vasorelaxation. Hypercontractile responses were normalised by fasudil (Rho kinase inhibitor) and 4-phenylbutyrate (4-PBA; endoplasmic-reticulum (ER) stress inhibitor). Ca2+ transients and Ca2+ channel expression were increased in CADASIL VSMCs, with increased expression of Rho guanine nucleotide-exchange factors (GEFs) and ER stress proteins. Vasorelaxation mechanisms were impaired in CADASIL, evidenced by decreased endothelial nitric oxide synthase (eNOS) phosphorylation and reduced cyclic guanosine 3′,5′-monophosphate (cGMP) levels, with associated increased soluble guanylate cyclase (sGC) oxidation, decreased sGC activity and reduced levels of the vasodilator hydrogen peroxide (H2O2). In VSMCs from CADASIL patients, sGC oxidation was increased and cGMP levels decreased, effects normalised by fasudil and 4-PBA. Cerebral vessels in CADASIL patients exhibited significant oxidative damage. In conclusion, peripheral vascular dysfunction in CADASIL is associated with altered Ca2+ homoeostasis, oxidative stress and blunted eNOS/sGC/cGMP signaling, processes involving Rho kinase and ER stress. We identify novel pathways underlying the peripheral arteriopathy induced by Notch3 gain-of-function mutation, phenomena that may also be important in cerebral vessels.

ORCID iDs

Neves, Karla B. ORCID logoORCID: https://orcid.org/0000-0001-5158-9263, Morris, Hannah E., Alves-Lopes, Rhéure, Muir, Keith W., Moreton, Fiona, Delles, Christian, Montezano, Augusto C. and Touyz, Rhian M.;
CORE (COnnecting REpositories)